ClinicalTrials.Veeva

Menu

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Lilly logo

Lilly

Status and phase

Completed
Phase 2

Conditions

Carcinoma, Non Small Cell Lung

Treatments

Drug: gemcitabine
Drug: carboplatin
Drug: cisplatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00191230
5489
B9E-US-S236

Details and patient eligibility

About

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically of cytologically confirmed non small cell lung cancer
  • No prior chemotherapy or radiation
  • No prior malignancy

Exclusion criteria

  • Pregnant or breastfeeding
  • Serious concomitant systemic disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems